<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1.0" />
    <meta http-equiv="X-UA-Compatible" content="ie=edge" />

    <title>OtiTopic</title>

    <link rel="shortcut icon" type="image/x-icon" href="img/favicon.png" />

    <!-- Nunito Google Font -->
    <link href="https://fonts.googleapis.com/css2?family=Nunito+Sans:ital@1&family=Open+Sans:wght@400;700&display=swap" rel="stylesheet">

    <!-- css styles -->
    <link rel="stylesheet" href="css/owl.carousel.min.css" />
    <link rel="stylesheet" href="css/owl.theme.default.min.css" />
    <link rel="stylesheet" href="css/icofont.min.css" />
    <link rel="stylesheet" href="css/bootstrap.min.css" />
    <link rel="stylesheet" href="css/style.css" />

    <style type="text/css">
        header {
            position: relative;
            background-color: black;
            height: 100vh;
            width: 100%;
            overflow: hidden;
        }

        header video {
            position: absolute;
            top: 50%;
            left: 50%;
            min-width: 100%;
            min-height: 100%;
            width: auto;
            height: auto;
            z-index: 0;
            -ms-transform: translateX(-50%) translateY(-50%);
            -moz-transform: translateX(-50%) translateY(-50%);
            -webkit-transform: translateX(-50%) translateY(-50%);
            transform: translateX(-50%) translateY(-50%);
        }

        header .container {
          position: relative;
          z-index: 2;
        }

        header .overlay {
          position: absolute;
          top: 0;
          left: 0;
          height: 100%;
          width: 100%;
          background-color: black;
          opacity: 0.5;
          z-index: 1;
        }

    </style>

</head>

<body>

    <!-- Start Pre-loader -->
    <div class="pre-loader-wrap">
        <div class="pre-loader triangle">
            <svg viewBox="0 0 86 80">
                <polygon points="43 8 79 72 7 72"></polygon>
            </svg>
            <span>Loading...</span>
        </div>
    </div>
    <!-- End Pre-loader -->

    <!-- Start header section -->
    <header class="header-area">
        <div class="overlay"></div>
        <video playsinline="playsinline" autoplay="autoplay" muted="muted" loop="loop">
            <source src="img/videos/iStock-469473726.mp4" type="video/mp4">
        </video>

        <div class="dope-nav-container breakpoint-off" id="headerStickyArea">
            <div class="container">
                <div class="row">
                    <!-- Main Menu -->
                    <nav class="dope-navbar justify-content-between" id="dopeNav">

                        <!-- Logo -->
                        <a class="nav-brand" href="index.html"><img src="img/otitopic-logo-header.svg" alt=""></a>

                        <!-- Navbar Toggler -->
                        <div class="dope-navbar-toggler">
                            <span class="navbarToggler"><span></span><span></span><span></span></span>
                        </div>

                        <!-- Menu -->
                        <div class="dope-menu">
                            <!-- close btn -->
                            <div class="dopecloseIcon">
                                <div class="cross-wrap"><span class="top"></span><span class="bottom"></span></div>
                            </div>

                            <!-- Nav Start -->
                            <div class="dopenav">
                                <ul id="nav">
                                    <li><a href="index.html" class="active">Home</a></li>
                                    <li><a href="about-us.html">About Us</a></li>
                                    <li><a href="therapies.html">Therapies</a></li>
                                    <li><a href="research.html">Research</a></li>
                                    <li><a href="technology.html">Technology</a></li>
                                    <li><a href="investors.html">Investors</a></li>
                                    <li><a href="careers.html">Careers</a></li>
                                    <li><a href="contact-us.html">Contact</a></li>
                                </ul>
                            </div>
                            <!-- Nav End -->
                        </div>
                    </nav>
                    <!-- Start Nav Overlay -->
                    <div class="overlay"></div>
                    <!-- End Nav Overlay -->
                </div>
            </div>
        </div>

        <!-- Start Home Banner -->
       
        <div class="page-banner home-page-banner">
            <div class="container">
                <div class="row header-content col-md-rev">
                    <div class="col-lg-10 col-md-12">
                        <h1>Revolutionizing Myocardial Infraction Management</h1>
                        <p>Our mission is to provide patients with a faster alternative for management of suspected myocardial infraction (MI).</p>
                    </div>
                </div>
            </div>
        </div>
       
        <!-- End Home Banner -->

    </header>
    <!-- End header section -->

    <!-- Start Main Page Wrapper -->
    <main>

        <!-- start about otitopic -->
        <section class="about-otitopic-section section-gap section-gap-top section-gap-bottom">
            <div class="content-area clearfix">
                <div class="left-col">
                    <img src="img/home-about.jpg" alt="thumbnail">
                    <h2>About Otitopic</h2>
                    <div class="details">
                        <p>Otitopic, Inc., founded in 2012, is a late-stage pharmaceutical company, with a track record of success in product drug delivery and drug device development. Otitopic has changed the route of administration of a reference listed drug (RLD) and is on track to file a 505(b)(2) NDA for sale and marketing in the US.</p>
                        <div class="btns">
                            <a href="#" class="read-more-btn-primary">Read More</a>
                        </div>
                    </div>
                </div>
                <div class="right-col">
                    <div class="timeline">
                        <div class="timeline-body">
                            
                            <div class="content-head">
                                <h2 class="title-head">Press Releases</h2>
                            </div>
                            
                            <div class="timeline-item">
                                <div class="content">
                                    <h2 class="title">Reducing Vascular Mortality in Patients With Suspected Acute MI </h2>
                                    <a href="">Read more</a>
                                </div>
                            </div>
                            <div class="timeline-item">
                                <div class="content">
                                    <h2 class="title">Otitopic New Clinical Trial Results Continue to Demonstrate Inhibition...</h2>
                                    <a href="">Read more</a>
                                </div>
                            </div>
                            <div class="timeline-item">
                                <div class="content">
                                    <h2 class="title">Otitopic Announces Results of Dose-Finding PK/PD Study for Asprihale®...</h2>
                                    <a href="">Read more</a>
                                </div>
                            </div>
                            <div class="timeline-item">
                                <div class="content">
                                    <h2 class="title">Otitopic Advances Asprihale® Into Pivotal PK/PD Study </h2>
                                    <a href="">Read more</a>
                                </div>
                            </div>
                            <div class="timeline-item">
                                <div class="content">
                                    <h2 class="title">Otitopic Pursues Additional New Indication for Dry Powder Inhalation of Aspirin as a...</h2>
                                    <a href="">Read more</a>
                                </div>
                            </div>
                            <div class="content-head">
                                <a href="" class="btn-outline-press">View All Press Releases</a>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
        </section>
        <!-- end about otitopic -->

        <!-- Push the boundaries -->
        <section class="push-the-boundaries-section section-gap section-gap-top section-gap-bottom">
            <div class="container">
                
                <div class="heart-attack-grid-2">
                    <div class="img-holder">
                        <img src="img/heart-attack.jpg" alt="">
                    </div>
                    <div class="text-content">
                        <h2>Management of suspected heart attack</h2>

                        <p>A myocardial infarction (MI), commonly known as a heart attack, occurs every 40 seconds in the US. Otitopic is committed to the development of a rapid therapy for the treatment of MI. Otitopic has developed a dry powder inhalation treatment for MI that enters the bloodstream in less than two minutes.</p>
                        <p>Myocardial infarction occurs when an interruption in blood supply causes heart cell death from lack of oxygen and nutrients. Myocardial infarctions are typically caused by the blockage of a coronary artery by atherosclerotic plaque, a mass of cholesterol and white blood cells in the artery wall. Otitopic has been working on the proprietary formulation since 2012 and is focused on bringing this therapy to market.</p>
                    </div>
                </div>
                
            </div> 
        </section>
        <!-- end why-choose-section -->

        <!-- start featured-project-section -->
        <section class="featured-project-section section-padding">
            <div class="container">
                <div class="row">
                    <div class="col-lg-12">
                        <div class="section-title-s5">
                            <h2>What we can offer</h2>
                        </div>
                    </div>
                </div>
            </div>
            <div class="content-area">
                <div class="project-grids clearfix">
                    <div class="grid" style="background: url('img/img-hover-1.jpg') center no-repeat;">
                        <div class="overlay">
                            <span class="count"><img src="img/icons/atomic.png" alt="icon"></span>
                            <div class="tag-area">Our Science</div>
                            <h3>Our Technology</h3>
                            <p>Asprihale® has been designed with deep lung deposition in mind. The formulation’s particles have been engineered to a specific size so that the inhaler produces the ideal aerodynamic profile for maximum absorption. Otitopic has been issued multiple patents worldwide and is the only company with the rights to market orally inhaled dry powder aspirin. </p>
                            <a href="#" class="btn-white">Learn More</a>
                        </div>
                    </div>
                    <div class="grid" style="background: url('img/img-hover-2.jpg') center center no-repeat;">
                        <div class="overlay">
                            <span class="count"><img src="img/icons/medical-computer.png" alt="icon"></span>
                            <div class="tag-area">Our Technology</div>
                            <h3>Our Technology</h3>
                            <p>Asprihale® has been designed with deep lung deposition in mind. The formulation’s particles have been engineered to a specific size so that the inhaler produces the ideal aerodynamic profile for maximum absorption. Otitopic has been issued multiple patents worldwide and is the only company with the rights to market orally inhaled dry powder aspirin. </p>
                            <a href="#" class="btn-white">Learn More</a>
                        </div>
                    </div>
                    <div class="grid" style="background: url('img/img-hover-3.jpg') center center no-repeat;">
                        <div class="overlay">
                            <span class="count"><img src="img/icons/pipe.png" alt="icon"></span>
                            <div class="tag-area">Our Pipeline</div>
                            <h3>Our Technology</h3>
                            <p>Asprihale® has been designed with deep lung deposition in mind. The formulation’s particles have been engineered to a specific size so that the inhaler produces the ideal aerodynamic profile for maximum absorption. Otitopic has been issued multiple patents worldwide and is the only company with the rights to market orally inhaled dry powder aspirin. </p>
                            <a href="#" class="btn-white">Learn More</a>
                        </div>
                    </div>
                    <div class="grid" style="background: url('img/img-hover-4.jpg') center center no-repeat;">
                        <div class="overlay">
                            <span class="count"><img src="img/icons/therapy.png" alt="icon"></span>
                            <div class="tag-area">Our Therapies</div>
                            <h3>Our Technology</h3>
                            <p>Asprihale® has been designed with deep lung deposition in mind. The formulation’s particles have been engineered to a specific size so that the inhaler produces the ideal aerodynamic profile for maximum absorption. Otitopic has been issued multiple patents worldwide and is the only company with the rights to market orally inhaled dry powder aspirin. </p>
                            <a href="#" class="btn-white">Learn More</a>
                        </div>
                    </div>
                </div>
            </div>
        </section>
        <!-- end featured-project-section -->

        <!-- Start testimonials section -->
        <section class="testimonials-section section-gap-top section-gap-bottom">
            <div class="container">
                <div class="row justify-content-center d-flex">
                    <div class="col-lg-10 gallery-wrap">
                        <div class="outer">
                            <div id="big" class="owl-carousel owl-theme portfolio-carousel">
                                <div class="item">
                                    <img src="img/icons/quote.svg" alt="quote">
                                    <h2>OTI-0726 would certainly have a meaningful clinical effect in patients. If you look at the underlying pathology, the longer the clotting process has progressed, the more stable the clot becomes. Attacking the clot earlier could abort or dampen the thrombotic process.</h2>

                                    <div class="author">
                                        <div class="line-separator">
                                            <img src="img/icons/line.png" alt="line icon">
                                        </div>
                                        <div>
                                            <h4>Interventional Cardiologist</h4>
                                            <p>Major Academic Medical Center</p>
                                        </div>
                                    </div>

                                </div>
                                <div class="item">
                                    <img src="img/icons/quote.svg" alt="quote">
                                    <h2>I am not perfectly systematic when it comes to recommending rescue aspirin to my patients. When aspirin comes up in conversation, I will mention that a rescue aspirin is a good idea in the event of a heart attack. Since the guideline update my patients and I have been discussing aspirin more often</h2>

                                    <div class="author">
                                        <div class="line-separator">
                                            <img src="img/icons/line.png" alt="line icon">
                                        </div>
                                        <div>
                                            <h4>Cardiologist KOL</h4>
                                            <p>Harbor-UCLA Medical Center</p>
                                        </div>
                                    </div>
                                    
                                </div>
                                <div class="item">
                                    <img src="img/icons/quote.svg" alt="quote">
                                    <h2>The major strength of this product is that it’s anti-platelet effects begin within 2 minutes. Asprihale® would begin inhibiting platelet aggregation much faster than our standard chewable aspirin </h2>

                                    <div class="author">
                                        <div class="line-separator">
                                            <img src="img/icons/line.png" alt="line icon">
                                        </div>
                                        <div>
                                            <h4>ER physician</h4>
                                            <p>WellStar West Georgia Medical Center</p>
                                        </div>
                                    </div>
                                    
                                </div>
                                <div class="item">
                                    <img src="img/icons/quote.svg" alt="quote">
                                    <h2>I don’t need to see outcomes data to believe that this product will help my patients. The chain of logic that connects early aspirin administration and better outcomes to faster platelet inhibition is sufficient for me to prescribe Asprihale®</h2>

                                    <div class="author">
                                        <div class="line-separator">
                                            <img src="img/icons/line.png" alt="line icon">
                                        </div>
                                        <div>
                                            <h4>Cardiology KOL</h4>
                                            <p>Harbor-UCLA Medical Center</p>
                                        </div>
                                    </div>
                                    
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
        </section>
        <!-- End testimonials section -->

        <!-- Start call to action section -->
        <section class="cta-section section-gap section-gap-top section-gap-bottom">
            <div class="container">
                <div class="row d-flex align-items-center col-md-rev">
                    <div class="col-lg-9 col-md-12">
                        <h2>Let’s provide you a faster alternative for management of suspected myocardial infarction (MI)</h2>
                        <div class="btn-flex">
                            <a href="contact-us.html" class="btn-outline">Get in touch</a>    
                        </div>
                    </div>
                </div>
            </div>
        </section>
        <!-- End call to action section -->

    </main>
    <!-- End Main Page Wrapper -->

  
    <!-- Start footer section -->
    <footer class="footer-section section-gap-top">
        <div class="container">
            <div class="grid-row-footer footer-top section-gap-bottom">

                <div class="footer-widgets">
                    <img class="footer-logo" src="img/otitopic-logo-footer.svg" alt="">
                    <p class="footer-brand-excerpt">OtiTopic, Inc. is a late-stage pharmaceutical company, with a track record of success in product drug delivery and drug service development.</p>
                    <ul class="social-lists">
                        <li><a href="#" target="__blank"><img src="img/icons/fb.svg"></a></li>
                        <li><a href="#" target="__blank"><img src="img/icons/in.svg"></a></li>
                        <li><a href="#" target="__blank"><img src="img/icons/tw.svg"></a></li>
                        <li><a href="#" target="__blank"><img src="img/icons/yt.svg"></a></li>
                    </ul>
                </div>

                <div class="footer-widgets">
                    <div class="single-widget">
                        <h4 class="wiget-title">Company</h4>
                        <ul class="list-style">
                            <li><a href="#">About us</a></li>
                            <li><a href="#">Careers</a></li>
                            <li><a href="#">Contact Us</a></li>
                            <li><a href="#">Blogs & News</a></li>
                        </ul>
                    </div>
                </div>

                <div class="footer-widgets">
                    <div class="single-widget">
                        <h4 class="wiget-title">Services</h4>
                        <ul class="list-style">
                            <li><a href="#">Our Science</a></li>
                            <li><a href="#">Our Research</a></li>
                            <li><a href="#">Our Pipeline</a></li>
                            <li><a href="#">Our Technologies</a></li>
                            <li><a href="#">Our Therapies</a></li>
                        </ul>
                    </div>
                </div>

                <div class="footer-widgets">
                    <div class="single-widget">
                        <h4 class="wiget-title">Investors</h4>
                        <ul class="list-style">
                            <li><a href="#">Investor Relation</a></li>
                            <li><a href="#">Press Release</a></li>
                            <li><a href="#">Company Presentation</a></li>
                        </ul>
                    </div>
                </div>

            </div>

            <div class="row copyright-bottom d-flex align-items-center">
                <div class="col-md-6">
                    <p>&copy; Copyright OtiTopic <span id="year"></span>. All Rights Reserved.</p>
                </div>
                <div class="col-md-6">
                    <ul>
                        <li><a href="privacy-policy.html">Privacy Policy</a></li>
                        <li><a href="terms-conditions.html">Terms & Conditions</a></li>
                    </ul>
                </div>
            </div>
        </div>
    </footer>
    <!-- End footer section -->

    <!-- Start Scroll Top -->
    <div class="scroll-top">
        <i class="icofont-rounded-up"></i>
    </div>
    <!-- End Scroll Top -->

    <!-- JS Files -->
    <script src="js/jquery-3.3.1.slim.min.js"></script>
    <script src="js/popper.min.js"></script>
    <script src="js/bootstrap.min.js"></script>
    <script src="js/owl.carousel.min.js"></script>
    <script src="js/dopeNav.js"></script>
    <script src="js/odometer.js"></script>
    <script src="js/tilt.jquery.min.js"></script>
    <script src="js/main.js"></script>
    <script>document.getElementById("year").innerHTML = new Date().getFullYear();</script>
   <!--  <script type="text/javascript">
        window.addEventListener("scroll", function() {
          let headerStickyArea = document.getElementById('headerStickyArea');

          if (window.pageYOffset > 0) {
            document.getElementById('headerStickyArea').style.position = 'fixed';
            document.getElementById('headerStickyArea').style.background = '#fff';
            document.getElementById('headerStickyArea').style.width = '100%';
          } else {
             document.getElementById('headerStickyArea').style.position = 'fixed';
            document.getElementById('headerStickyArea').style.background = 'transparent';
            document.getElementById('headerStickyArea').style.width = '100%';
          }
        });
    </script> -->

</body>

</html>